Risk factors for disease progression can include: prostatic enlargement > 30–40 mL, prostate-specific antigen (PSA) > 1.5 ng/mL, advanced age, larger prostate volume (PV), larger post-void residual volume (PVR), and lower maximal urinary flow rate (Qmax). The gene discussed is KLK3; the disease is benign prostatic hyperplasia.